M Andrew Nesbit Selected Research

type 1 familial Hypocalciuric hypercalcemia

10/2017	Cinacalcet corrects hypercalcemia in mice with an inactivating Gα11 mutation.
5/2016	Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein α-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders.
1/2016	A G-protein Subunit-α11 Loss-of-Function Mutation, Thr54Met, Causes Familial Hypocalciuric Hypercalcemia Type 2 (FHH2).
7/2014	Mutational analysis of the adaptor protein 2 sigma subunit (AP2S1) gene: search for autosomal dominant hypocalcemia type 3 (ADH3).
6/2013	Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia.
1/2013	Mutations in AP2S1 cause familial hypocalciuric hypercalcemia type 3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Andrew Nesbit Research Topics

Disease

8	Hypoparathyroidism 01/2020 - 05/2004
7	Hypocalcemia 01/2017 - 09/2004
6	Hereditary Corneal Dystrophies 11/2020 - 07/2015
6	Hypercalcemia (Milk Alkali Syndrome) 10/2017 - 09/2004
6	type 1 familial Hypocalciuric hypercalcemia 10/2017 - 01/2013
6	Deafness (Deaf Mutism) 06/2013 - 05/2004
5	Neoplasms (Cancer) 03/2014 - 10/2005
3	COVID-19 01/2022 - 01/2021
3	Hypercalciuria 01/2016 - 03/2014
3	Barakat syndrome 10/2009 - 05/2004
2	Fibrosis (Cirrhosis) 01/2017 - 01/2003
2	Hyperuricemia 01/2017 - 01/2003
2	Hyperglycemia 01/2017 - 03/2014
2	Carcinogenesis 05/2016 - 04/2013
2	Dent Disease 02/2010 - 01/2009
1	Congenital Heart Defects (Congenital Heart Defect) 01/2021
1	Infections 01/2021
1	X-Linked Hypoparathyroidism 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 09/2019
1	Renal Insufficiency (Renal Failure) 01/2017
1	Inflammation (Inflammations) 01/2017
1	Kidney Diseases (Kidney Disease) 01/2017
1	Glucose Intolerance 01/2017
1	Uveal melanoma 05/2016
1	Juvenile Epithelial of Meesmann Corneal Dystrophy 03/2016
1	Corneal Opacity 03/2016
1	Kyphosis 01/2016
1	Keratoconus 01/2016
1	Amyloid Plaque 07/2015
1	Alopecia (Baldness) 03/2014
1	Metabolic Bone Diseases (Osteopenia) 03/2014
1	Cushing Syndrome 03/2014
1	Hypercholesterolemia 03/2014
1	Hyperinsulinism (Hyperinsulinemia) 03/2014
1	Obesity 03/2014
1	Osteoporosis 03/2014
1	Hypertriglyceridemia 03/2014
1	Primary Hyperparathyroidism 10/2012
1	Genomic Instability 10/2012
1	Multiple Endocrine Neoplasia Type 1 10/2012
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 10/2012
1	congenita Spondyloepiphyseal dysplasia 02/2012
1	Osteoarthritis 02/2012
1	Autosomal Recessive Hypoparathyroidism 05/2010

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2009
8	Calcium-Sensing ReceptorsIBA 10/2017 - 09/2004
7	CalciumIBA 01/2020 - 09/2004
7	GTP-Binding Proteins (G-Protein)IBA 10/2017 - 06/2013
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 04/2005
6	Parathyroid Hormone (Parathormone)IBA 01/2020 - 09/2004
4	Transcription Factors (Transcription Factor)IBA 06/2010 - 04/2005
3	Cinacalcet (Sensipar)FDA Link 10/2017 - 04/2016
3	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2016 - 02/2012
3	GATA3 Transcription FactorIBA 06/2013 - 05/2004
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	AntibodiesIBA 01/2021 - 01/2021
2	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2020 - 01/2020
2	Uric Acid (Urate)IBA 01/2017 - 01/2003
2	Arginine (L-Arginine)FDA Link 01/2017 - 06/2013
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2016 - 07/2015
2	NucleotidesIBA 06/2013 - 10/2012
2	Protons (Proton)IBA 02/2010 - 01/2009
2	AntiportersIBA 02/2010 - 01/2009
2	ChloridesIBA 02/2010 - 01/2009
1	SARS-CoV-2 spike proteinIBA 01/2021
1	ElementsIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 09/2019
1	UromodulinIBA 01/2017
1	Cysteine (L-Cysteine)FDA Link 01/2017
1	Keratins (Keratin)IBA 03/2016
1	Keratin-12 (Keratin 12)IBA 03/2016
1	Natriuretic PeptidesIBA 01/2016
1	N- (2- hydroxy- 3- (2- cyano- 3- chlorophenoxy)propyl)- 1,1- dimethyl- 2- (2- nephthyl)ethylamineIBA 09/2015
1	Congo RedIBA 07/2015
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2015
1	Hematoxylin (Haematoxylon)IBA 07/2015
1	Sigma FactorIBA 07/2014
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2014
1	Adrenocorticotropic Hormone (ACTH)FDA Link 03/2014
1	CorticosteroneIBA 03/2014
1	GlucocorticoidsIBA 03/2014
1	LuciferasesIBA 03/2014
1	OsteocalcinIBA 03/2014
1	AdiponectinIBA 03/2014
1	Isoleucine (L-Isoleucine)FDA Link 06/2013
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 06/2013
1	Carrier Proteins (Binding Protein)IBA 06/2013
1	Guanine NucleotidesIBA 06/2013
1	Estrogen ReceptorsIBA 06/2013
1	Platelet-Derived Growth FactorIBA 04/2013
1	Phosphotransferases (Kinase)IBA 04/2013
1	Single-Stranded DNA (DNA, Single Stranded)IBA 10/2012
1	Cyclin D1IBA 10/2012
1	CollagenIBA 02/2012
1	MutagensIBA 02/2012
1	Amino Acids FDA Link 05/2010

Therapy/Procedure

4	Therapeutics 01/2018 - 03/2016
2	Slit Lamp 01/2021 - 03/2016
1	Self-Testing 01/2021
1	Oral Administration 01/2017